Great analysis and summary Chris. I posted this on the Diaboogle Facebook page.
As a community the DOC should be constantly pushing the FDA to improve these standards. For folks with type 1 this is important stuff. Though I know from an event I attended several years ago it’s less of an issue for people with T2.